Richard A. P. Takx

Richard A. P. Takx

Auto-generated profile, based on publicly available information

Richard A. P. Takx

Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in European Journal of Radiology
Verified
Journal Article
Open access
LKLouise C.D. Konijn
Louise C.D. Konijn
RTRichard A.P. Takx
Richard A.P. Takx
Pim de JongPim de Jong
Pim de Jong
MSMarlon I. Spreen
Marlon I. Spreen
HVHugo T.C. Veger
Hugo T.C. Veger
HOHendrik van Overhagen
Hendrik van Overhagen
Within five years after presentation 50-60% of patients with chronic limb-threatening ischemia (CLI) have died or had an amputation. We assessed the predictive value of lower extremity arterial calcification on computed tomography (CT) characteristics on both 7-years amputation-free survival and 10-years all-cause mortality in patients with CLI. Included were 89 CLI patients (mean age 73.1 ± 11.6 years) who underwent a CT angiography of the lower extremities. In the femoropopliteal and crural arteries based on a CT score the following calcification characteristics were assessed: severity, annularity, thickness and continuity. The predictive value of different arterial calcification characteristics was analysed by age- and sex-adjusted multivariate Cox regression analysis. Complete annular calcifications were common (femoropopliteal 43.7%, n = 38; crural, 63.2%, n = 55). Mean survival was 278.4 weeks (95% CI 238.77-318.0 weeks). Patients with complete annular calcifications had a higher all-cause 10-year mortality (femoropopliteal unadjusted HR 1.64, p = 0.04 and adjusted for age and sex HR 1.68, p = 0.04; crural unadjusted HR 1.92, p = 0.02, adjusted for age and sex HR 2.29, p = 0.006) than patients with other calcification characteristics. Annularity of calcification of both femoropopliteal and crural arteries is a predictor for 10-year all-cause survival, its hazard being even higher than the traditional prognostic risk factors for CLI and therefore could be involved in the poor survival of these patients.

9 June 2016 in Diabetes Care
Verified
Journal Article
Open access
PDF file
CCCsilla Celeng
Csilla Celeng
PMPál Maurovich-Horvat
Pál Maurovich-Horvat
BGBrian B. Ghoshhajra
Brian B. Ghoshhajra
BMBéla Merkely
Béla Merkely
TLTim Leiner
Tim Leiner
RTRichard A.P. Takx
Richard A.P. Takx
OBJECTIVE: The usefulness of coronary computed tomography angiography (CTA) for the evaluation of coronary artery disease (CAD) in patients with diabetes is ambiguous. We therefore performed a meta-analysis of studies reporting event rates and hazard ratios (HR) to determine the prognostic value of CTA in this patient population. RESEARCH DESIGN AND METHODS: We searched PubMed and Embase up to November 2015. Study subjects’ characteristics, events (all-cause mortality or cardiac death, nonfatal myocardial infarction, unstable angina pectoris, stroke, revascularization), and events excluding revascularization were collected. We calculated the prevalence of obstructive and nonobstructive CAD on CTA, annualized event rates, and pooled unadjusted and adjusted HR using a generic inverse random model. RESULTS: Eight studies were eligible for inclusion into this meta-analysis, with 6,225 participants (56% male; weighted age, 61 years) with a follow-up period ranging from 20 to 66 months. The prevalence of obstructive CAD, nonobstructive CAD, and no CAD was 38%, 36%, and 25%, respectively. The annualized event rate was 17.1% for obstructive CAD, 4.5% for nonobstructive CAD, and 0.1% for no CAD. Obstructive and nonobstructive CAD were associated with an increased HR of 5.4 and 4.2, respectively. A higher HR for obstructive CAD was observed in studies including revascularization compared with those that did not (7.3 vs. 3.7, P = 0.124). CONCLUSIONS: CTA in patients with diabetes allows for safely ruling out future events, and the detection of CAD could allow for the identification of high-risk patients in whom aggressive risk factor modification, medical surveillance, or elective revascularization could potentially improve survival.

1 March 2023 in Stroke
Verified
Journal Article
Open access
FKFrans Kauw
Frans Kauw
BVBirgitta K Velthuis
Birgitta K Velthuis
RTRichard A P Takx
Richard A P Takx
MGMarco Guglielmo
Marco Guglielmo
MCMaarten J. M. Cramer
Maarten J. M. Cramer
JDJan Willem Dankbaar
Jan Willem Dankbaar
Background: Identifying cardioembolic sources in patients with acute ischemic stroke is important for the choice of secondary prevention strategies. We prospectively investigated the yield of admission (spectral) nongated cardiac computed tomography angiography (CTA) to detect cardioembolic sources in stroke. Methods: Participants of the ENCLOSE study (Improved Prediction of Recurrent Stroke and Detection of Small Volume Stroke) with transient ischemic attack or acute ischemic stroke with assessable nongated head-to-heart CTA at the University Medical Center Utrecht were included between June 2017 and March 2022. The presence of cardiac thrombus on cardiac CTA was based on a Likert scale and dichotomized into certainly or probably absent versus possibly, probably, or certainly present. The diagnostic certainty of cardiac thrombus was evaluated again on spectral computed tomography reconstructions. The likelihood of a cardioembolic source was determined post hoc by an expert panel in patients with cardiac thrombus on CTA. Parametric and nonparametric tests were used to compare the outcome groups. Results: Forty four (12%) of 370 included patients had a cardiac thrombus on admission CTA: 35 (9%) in the left atrial appendage and 14 (4%) in the left ventricle. Patients with cardiac thrombus had more severe strokes (median National Institutes of Health Stroke Scale score, 10 versus 4; P =0.006), had higher clot burden (median clot burden score, 9 versus 10; P =0.004), and underwent endovascular treatment more often (43% versus 20%; P <0.001) than patients without cardiac thrombus. Left atrial appendage thrombus was present in 28% and 6% of the patients with and without atrial fibrillation, respectively ( P <0.001). The diagnostic certainty for left atrial appendage thrombus was higher for spectral iodine maps compared with the conventional CTA ( P <0.001). The presence of cardiac thrombus on CTA increased the likelihood of a cardioembolic source according to the expert panel ( P <0.001). Conclusions: Extending the stroke CTA to cover the heart increases the chance of detecting cardiac thrombi and helps to identify cardioembolic sources in the acute stage of ischemic stroke with more certainty. Spectral iodine maps provide additional value for detecting left atrial appendage thrombus. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04019483.

1 July 2020 in European Journal of Radiology
Verified
Journal Article
Closed access
LKLouise Konijn
Louise Konijn
HOHendrik van Overhagen
Hendrik van Overhagen
RTRichard A.P. Takx
Richard A.P. Takx
Pim de JongPim de Jong
Pim de Jong
HVHugo T.C. Veger
Hugo T.C. Veger
Willem . P.Th.M MaliWillem . P.Th.M Mali
Willem . P.Th.M Mali

1 February 2017 in European Journal of Radiology
Verified
Journal Article
Closed access
MKMihály Károlyi
Mihály Károlyi
BSBalint Szilveszter
Balint Szilveszter
MKMárton Kolossváry
Márton Kolossváry
RTRichard A.P Takx
Richard A.P Takx
CCCsilla Celeng
Csilla Celeng
PMPál Maurovich-Horvat
Pál Maurovich-Horvat

29 September 2016 in European Radiology
Verified
Journal Article
Open access
PDF file
RTRichard A. P. Takx
Richard A. P. Takx
RKRadko Krissak
Radko Krissak
CFChristian Fink
Christian Fink
VBValentin Bachmann
Valentin Bachmann
THThomas Henzler
Thomas Henzler
PAPaul Apfaltrer
Paul Apfaltrer
To investigate the relationship between image quality and patient size at 100 kilovoltage (kV) compared to 120 kV ECG-gated Triple-Rule-Out CT angiography (TRO-CTA).